Proteomic profiling of human liver biopsies: Hepatitis C virus–induced fibrosis and mitochondrial dysfunction
Authors:
- Deborah L. DiamondDDDeborah L. Diamond
- Robert L. CarithersRCRobert L. Carithers
- David G. CampDCDavid G. Camp
- Richard D. SmithRSRichard D. Smith
Open Access
- 24 August 2007
- journal article
- viral hepatitis
- Published by Wolters Kluwer Health in Hepatology
- Vol. 46 (3) , 649-657
Abstract
Liver biopsies from hepatitis C virus (HCV)-infected patients offer the unique opportunity to study human liver biology and disease in vivo . However, the low protein yields associated with these small samples present a significant challenge for proteomic analysis. In this study we describe the application of an ultrasensitive proteomics platform for performing robust quantitative proteomic studies on microgram amounts of HCV-infected human liver tissue from 15 patients at different stages of fibrosis. A high-quality liver protein database containing 5,920 unique protein identifications supported high throughput quantitative studies using 16O/18O stable isotope labeling in combination with the accurate mass and time (AMT) tag approach. A total of 1,641 liver biopsy proteins were quantified, and analysis of variance (ANOVA) identified 210 proteins exhibiting statistically significant differences associated with fibrosis stage. Hierarchical clustering showed that biopsies representative of later fibrosis stages (for example, Batts-Ludwig stages 3–4) exhibited a distinct protein expression profile, indicating an apparent down-regulation of many proteins when compared with samples from earlier fibrosis stages (for example, Batts-Ludwig stages 0–2). Functional analysis of these signature proteins suggests that impairment of key mitochondrial processes including fatty acid oxidation and oxidative phosphorylation, and response to oxidative stress and reactive oxygen species occurs during advanced stage 3 to 4 fibrosis. Conclusion: The results reported here represent a significant advancement in clinical proteomics providing to our knowledge, the first demonstration of global proteomic alterations accompanying liver disease progression in patients chronically infected with HCV. Our findings contribute to a generally emerging theme associating oxidative stress and hepatic mitochondrial dysfunction with HCV pathogenesis. (Hepatology 2007.)Keywords
This publication has 35 references indexed in Scilit:
- Modification of Host Lipid Raft Proteome upon Hepatitis C Virus ReplicationMolecular & Cellular Proteomics, 2006
- HepatoProteomics: Applying proteomic technologies to the study of liver function and diseaseHepatology, 2006
- Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic repliconProteomics, 2006
- Proteome Analysis of Liver Cells Expressing a Full-Length Hepatitis C Virus (HCV) Replicon and Biopsy Specimens of Posttransplantation Liver from HCV-Infected PatientsJournal of Virology, 2005
- Quantitative Proteome Analysis of Human Plasma following in Vivo Lipopolysaccharide Administration Using 16O/18O Labeling and the Accurate Mass and Time Tag ApproachMolecular & Cellular Proteomics, 2005
- Probability-Based Evaluation of Peptide and Protein Identifications from Tandem Mass Spectrometry and SEQUEST Analysis: The Human ProteomeJournal of Proteome Research, 2004
- Use of Artificial Neural Networks for the Accurate Prediction of Peptide Liquid Chromatography Elution Times in Proteome AnalysesAnalytical Chemistry, 2003
- ESI-FTICR mass spectrometry employing Data-dependent external ion selection and accumulationJournal of the American Society for Mass Spectrometry, 2002
- An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein databaseJournal of the American Society for Mass Spectrometry, 1994
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989